Minocycline for management of Japanese encephalitis: A case report

Area of Science:

• Neuroscience
• Infectious Diseases
• Virology

Background:

• Japanese encephalitis virus (JEV) causes acute encephalitis syndrome, leading to significant neurological disability and high mortality (30% case fatality rate).
• Current treatment for JEV infection is primarily conservative, as no specific antiviral therapies are available.
• Limited clinical evidence suggests potential benefit from minocycline, while preclinical and in silico studies have identified other candidate compounds.

Purpose of the Study:

• To provide a comprehensive overview of potential therapeutic options for Japanese encephalitis based on existing literature.
• To highlight promising synthetic and natural compounds identified through preclinical and in silico analyses as future JEV therapies.
• To present a case study of successful JEV treatment and neurological recovery in a resource-limited environment.

Main Methods:

• Literature review of potential therapeutic agents for Japanese encephalitis.
• Analysis of preclinical and in silico studies identifying novel compounds.
• Case report detailing the treatment and outcome of a patient with Japanese encephalitis.

Main Results:

• The literature search identified several potential therapeutic avenues for JEV, though clinical validation is pending for most.
• Minocycline shows some limited evidence of efficacy in clinical trials.
• A described case demonstrated significant neurological recovery following treatment in a resource-poor setting, suggesting the potential for effective management even with limited resources.

Conclusions:

• There is an urgent need for effective antiviral therapies against Japanese encephalitis virus.
• Future research should focus on validating promising compounds identified in preclinical and in silico studies.
• Successful management of JEV, even in resource-limited settings, is achievable and warrants further investigation.